Login / Signup

Use of Rituximab for persistent EBV DNAemia, and Its effect on donor-specific antibody development in pediatric renal transplant recipients: A case series.

Dechu P PuliyandaStanley C JordanIrene K KimMitasha PatelAnand MurthyEdmund HuangXiaohai ZhangNancy ReinsmoenElaine S KamilMieko Toyoda
Published in: Pediatric transplantation (2021)
While early intervention with rituximab in pediatric patients with PEBV may reduce viral load and PTLD, we observed a slower development of de novo DSA, and rejection and maintenance of eGFR.
Keyphrases
  • diffuse large b cell lymphoma
  • epstein barr virus
  • randomized controlled trial
  • epidermal growth factor receptor
  • hodgkin lymphoma
  • chronic lymphocytic leukemia
  • young adults
  • childhood cancer